Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,413 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,413

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

for

Urinary Retention, Pelvic Organ Prolapse,

Location: Kyle TX, Austin TX, Round Rock TX

Sponsor: University of Texas at Austin

Sex: Female

Age: 18+

Code: NCT05860634

Recruiting

Virtue® SAB in the Treatment of Coronary ISR Trial

for

Coronary Artery Disease

Location: Kyle TX, Wichita KS, Pensacola FL, Nashville TN,

Sponsor: Orchestra BioMed, Inc

Sex: All

Age: 18+

Code: NCT07045194

Recruiting

Study of BHV-1300 in Graves' Disease

for

Graves Disease

Location: Shavano Park TX, Houston TX, Dallas TX, Memphis TN,

Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT06980649

Phase1, Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for

Graves Disease

Location: Shavano Park TX, San Antonio TX, Houston TX, Dallas TX,

Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase3, Recruiting

SportsPro: Post-Market Clinical Follow Up Study

for

Shoulder Injuries, Knee Injuries, Hip Injuries

Location: San Antonio TX, Englewood CO, Phoenix AZ

Sponsor: Stryker Endoscopy

Sex: All

Age: 18+

Code: NCT06320925

Recruiting

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

for

Psoriasis

Location: San Antonio TX, Birmingham AL, Chula Vista CA

Sponsor: InventisBio Co., Ltd

Sex: All

Age: 18 - 70

Code: NCT07489885

Phase2, Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for

Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,

Location: San Antonio TX, Bryant AR, Birmingham AL,

Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase2, Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

for

Chronic Inducible Urticaria, Cold Urticaria,

Location: San Antonio TX, Oklahoma City OK, Birmingham AL,

Sponsor: Celldex Therapeutics

Sex: All

Age: 18+

Code: NCT07266402

Phase3, Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for

Idiopathic Short Stature

Location: California City CA, Houston TX, Dallas TX, Lafayette LA,

Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase2, Recruiting

Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia

for

Achondroplasia

Location: San Antonio TX, Houston TX, Cincinnati OH, Chicago IL,

Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 2 - 17

Code: NCT07441876

Phase2, Phase3, Recruiting

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for

Osteoarthritis, Overweight or Obesity

Location: Shavano Park TX, San Antonio TX, Bellaire TX,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07353931

Phase3, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for

Overweight, Obesity

Location: Shavano Park TX, San Antonio TX, Missouri City TX,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07392190

Phase3, Recruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

for

Overweight, Obesity

Location: Shavano Park TX, San Antonio TX, Houston TX, Weslaco TX,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 8 - 18

Code: NCT07253285

Phase3, Recruiting

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

for

Obesity, Overweight, Diabetes Mellitus, Type 2

Location: Shavano Park TX, Richmond TX, Houston TX, Dallas TX,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07215559

Phase2, Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for

Metabolic Dysfunction-Associated Steatotic Liver Disease

Location: Shavano Park TX, San Antonio TX, Austin TX, Houston TX,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07165028

Phase3, Recruiting

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

for

Hypercholesterolemia

Location: Shavano Park TX, San Antonio TX, Round Rock TX,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07477704

Phase2, Recruiting

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

for

Diabetes Mellitus, Type 2

Location: Shavano Park TX, Houston TX, Dallas TX, Memphis TN,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 18 - 70+

Code: NCT07415954

Phase2, Recruiting

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

for

COVID-19

Location: Shavano Park TX, Shreveport LA, Atlanta GA, Chicago IL,

Sponsor: Pfizer

Sex: All

Age: 0 - 17

Code: NCT05261139

Phase3, Recruiting

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for

Atopic Dermatitis

Location: San Antonio TX, Sugar Land TX, Dallas TX, Plainfield IN,

Sponsor: Enveda Therapeutics

Sex: All

Age: 18+

Code: NCT07643766

Phase2, Recruiting

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

for

Infertility (IVF Patients)

Location: San Antonio TX, Houston TX

Sponsor: Urmila DIwekar

Sex: Female

Age: 20 - 50

Code: NCT07148999

Phase1, Phase2, Recruiting

Paid Clinical Trials New Braunfels

Filter results

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

Virtue® SAB in the Treatment of Coronary ISR Trial

Study of BHV-1300 in Graves' Disease

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

SportsPro: Post-Market Clinical Follow Up Study

Interested in new trials?

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera